![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Wolff, Andreas W.; Peine, Joerg; Hoefler, Josef; Zurek, Gabriela; Hemker, Claus und Lingor, Paul
(2024):
SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants.
In: Cns Drugs
[PDF, 1MB]
Koch, Jan C; Leha, Andreas; Bidner, Helen; Cordts, Isabell; Dorst, Johannes; Günther, René; Zeller, Daniel; Braun, Nathalie; Metelmann, Moritz; Corcia, Philippe; Cruz, Elisa De La; Weydt, Patrick; Meyer, Thomas; Großkreutz, Julian; Soriani, Marie-Hélène; Attarian, Shahram; Weishaupt, Jochen H; Weyen, Ute; Kuttler, Josua; Zurek, Gabriela; Rogers, Mary-Louise; Feneberg, Emily; Deschauer, Marcus 
ORCID: https://orcid.org/0000-0001-6116-6790; Neuwirth, Christoph; Wuu, Joanne; Ludolph, Albert C; Schmidt, Jens; Remane, Yvonne; Camu, William; Friede, Tim; Benatar, Michael; Weber, Markus und Lingor, Paul
(2024):
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS). A phase 2, randomised, double-blind, placebo-controlled trial.
In: Lancet Neurology, Bd. 23, Nr. 11: S. 1133-1146
[PDF, 849kB]
ORCID: https://orcid.org/0000-0001-6116-6790; Neuwirth, Christoph; Wuu, Joanne; Ludolph, Albert C; Schmidt, Jens; Remane, Yvonne; Camu, William; Friede, Tim; Benatar, Michael; Weber, Markus und Lingor, Paul
(2024):
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS). A phase 2, randomised, double-blind, placebo-controlled trial.
In: Lancet Neurology, Bd. 23, Nr. 11: S. 1133-1146
[PDF, 849kB]
Schoretsanitis, Georgios; Paulzen, Michael; Unterecker, Stefan; Schwarz, Markus; Conca, Andreas; Zernig, Gerald; Gründer, Gerhard; Haen, Ekkerhard; Baumann, Pierre; Bergemann, Niels; Clement, Hans Willi; Domschke, Katharina; Eckermann, Gabriel; Egberts, Karin; Gerlach, Manfred; Greiner, Christine; Havemann-Reinecke, Ursula; Hefner, Gudrun; Helmer, Renate; Janssen, Ger; Jaquenoud-Sirot, Eveline; Laux, Gerd; Messer, Thomas; Mössner, Rainald; Müller, Matthias J.; Pfuhlmann, Bruno; Riederer, Peter; Saria, Alois; Schoppek, Bernd; Gracia, Margarete Silva; Stegmann, Benedikt; Steimer, Werner; Stingl, Julia C.; Uhr, Manfred; Ulrich, Sven; Waschgler, Roland; Zurek, Gabriela und Hiemke, Christoph
(2018):
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017;a tool for clinicians.
In: World Journal of Biological Psychiatry, Bd. 19, Nr. 3: S. 162-174